Skopos Labs, Inc. Ardelyx, Inc. Transaction History
Skopos Labs, Inc.
- $497 Million
- Q2 2025
A detailed history of Skopos Labs, Inc. transactions in Ardelyx, Inc. stock. As of the latest transaction made, Skopos Labs, Inc. holds 1,401 shares of ARDX stock, worth $7,397. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,401
Previous 1,401
-0.0%
Holding current value
$7,397
Previous $6,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ARDX
# of Institutions
222Shares Held
167MCall Options Held
517KPut Options Held
1.61M-
Black Rock Inc. New York, NY17.6MShares$92.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16MShares$84.6 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X015.1MShares$79.5 Million0.03% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny11.7MShares$61.6 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C311.5MShares$60.5 Million0.06% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $816M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...